In this study, we synthesized and characterized the antibacterial activity of three naturally occurring oxyprenylated chalcones {xinjiachalcone A (1), (2E)-1-{2,6-dihydroxy-4-[(3-methylbut-2-enyl)oxy]phenyl}-3-(4-hydroxyphenyl)prop-2-en-1-one (2), (2E)-1-{2,6-dihydroxy-4-[(3-methylbut-2-enyl)oxy]phenyl}-3-phenylprop-2-en-1-one (3), and lawsone 2-isopentenyl ether (4)}. Using several strains of Helicobacter pylori, including clinical ones, minimum inhibitory concentration (MIC) values and bactericidal activities of these compounds were determined. Xinjiachalcone A (1), active principle of Glycyrrhiza inflata Batalin, was the most effective compound, showing both a low MIC and a strong bactericidal activity against H. pylori. This study suggests that these compounds represent potential natural molecules for the prevention and treatment of H. pylori associated diseases.
EpifanoF., GenoveseS., MenghiniL., CuriniM. (2007) Chemistry and pharmacology of oxyprenylated secondary plant metabolites. Phytochemistry, 68, 939–953.
2.
GenoveseS., CuriniM., EpifanoF. (2009) Chemistry and biological activity of azoprenylated secondary metabolites. Phytochemistry, 70, 1082–1091.
3.
BlaserM.J., AthertonJ.C. (2004) Helicobacter pylori persistence: biology and disease. Journal of Clinical Investigation, 113, 321–333.
4.
AthertonJ.C. (2006) The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annual Review of Pathology Mechanism of Disease, 1, 63–96.
5.
ZhouL., SungJ.J., LinS. (2003) A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chinese Medicine Journal, 116, 11–14.
6.
LeyC., MoharA., GuarnerJ. (2004) Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers, 13, 4–10.
7.
LeeC.W., RickmanB., RogersA.B., GeZ., WangT.C., FoxJ.G. (2008) Helicobcater pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Research, 68, 3540–3548.
8.
MalfertheinerP., MegraudF., O'MorainC., BazzoliF., El-OmarE., GrahamD., HuntR., RokkasT., VakilN., KuipersE.J. (2007) The European Helicobacter Study Group (EHSG). Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut, 56, 772–781.
9.
GrahamD.Y., ShiotaniM.D. (2008) Newer concepts regarding resistance in the treatment Helicobacter pylori infections. Nature Clinic Practice Gastroenterology & Hepatology, 5, 321–331.
10.
MegraudF. (2004) H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut, 53, 1374–1384.
TouatiE., MichelV., CorreiaM., MenghiniL., GenoveseS., CuriniM., EpifanoF. (2009) Boropinic acid, a novel inhibitor of Helicobacter pylori stomach colonization. Journal of Antimicrobial Chemotherapy, 9, 210–211.
13.
Ribeiro da SilvaC., MichelV., GenoveseS., PrevostM.C., EpifanoF., TouatiE. (2012) Anti-Helicobacter pylori activities of natural isopentenyloxycinnamyl derivatives from Boronia pinnata. Natural Product Communications, 7, 1347–1350.
14.
IwasakiN., BabaM., AishanH., OkadaY., OkuyamaT. (2009) Studies of traditional folk medicines in Xinjiang Uighur autonomous II. Research for chemical constituents of Xinjiang licorice. Heterocycles, 78, 1581–1587.
15.
JakupovicJ., GrenzM., BohlmannF., MungaiG.M. (1990) 12p-Hydroxyabieta-7,13-diene and other constituents from east African Helychrisum species. Phytochemistry, 29, 1589–1590.
16.
BohlmannF., ZderoC. (1982) Chemotaxonomy of the genus Pleiotaxis. Phytochemistry, 21, 1434–1438.
17.
BohlmannF., ZderoC. (1990) Glycerol derivatives and other constituents from Metalasia species. Phytochemistry, 29, 2179–2180.
18.
InoueK., UedaS., NayeshiroH., MoritomeN., InouyeH. (1984) Biosynthesis of naphthoquinones and anthraquinones in Streptocarpus dunnii cell cultures. Phytochemistry, 23, 313–318.
19.
FioritoS., EpifanoF., BruyereC., KissR., GenoveseS. (2013) In vitro anti-proliferative effect of naturally occurring oxyprenylated chalcones. Natural Product Communications, 8, 1089–1092.
20.
BruyereC., GenoveseS., LallemandB., Ionescu-MotatuA., CuriniM., KissR., EpifanoF. (2011) Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines. Bioorganic & Medicinal Chemistry Letters, 21, 4173–4178.
21.
RaymondJ, LamarqueD., KalachN., ChaussadeS., BurucoaC. (2010) High level of antimicrobial resistance in French Helicobacter pylori isolates. Helicobacter, 15, 21–27.
